Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Free Cash Flow (2016 - 2025)

Surgery Partners' Free Cash Flow history spans 12 years, with the latest figure at $90.6 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 1.68% year-over-year to $90.6 million; the TTM value through Dec 2025 reached $195.6 million, down 6.72%, while the annual FY2025 figure was $195.6 million, 6.72% down from the prior year.
  • Free Cash Flow for Q4 2025 was $90.6 million at Surgery Partners, up from $63.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $90.6 million in Q4 2025 and bottomed at -$16.7 million in Q1 2025.
  • The 5-year median for Free Cash Flow is $39.2 million (2021), against an average of $35.9 million.
  • The largest YoY upside for Free Cash Flow was 2166.67% in 2022 against a maximum downside of 376.79% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at $5.6 million in 2021, then plummeted by 376.79% to -$15.5 million in 2022, then skyrocketed by 376.13% to $42.8 million in 2023, then skyrocketed by 108.18% to $89.1 million in 2024, then grew by 1.68% to $90.6 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Free Cash Flow are $90.6 million (Q4 2025), $63.8 million (Q3 2025), and $57.9 million (Q2 2025).